1-3 of 3
Sharon Anbumalar Lionel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dose Optimization of Check-Point Inhibitors: A Comparison of Standard Dose and Low Dose Nivolumab in Relapsed/Refractory Hodgkin Lymphoma

Chirag Trivedi, Sujith Kumar, Sushil Selvarajan, Sharon Anbumalar Lionel, Anup J Devasia, Fouzia N., Uday Kulkarni, Aby Abraham, Alok Srivastava, Biju George, Vikram Mathews, Anu Korula
Journal: Blood
Blood (2024) 144 (Supplement 1): 3048.
https://doi.org/10.1182/blood-2024-198979
Published: 2024
Journal Articles

Fludarabine and Melphalan Reduced Toxicity Versus a Myeloablative Fludarabine and Busulfan Conditioning Regimen for Acute Myeloid Leukemia

Vikram Mathews, Uday Kulkarni, Sushil Selvarajan, Nutan Damodar Joshi, Fouzia NA, Anu Korula, Sharon Anbumalar Lionel, Kavitha M Lakshmi, Alok Srivastava, Biju George, Aby Abraham
Journal: Blood
Blood (2023) 142 (Supplement 1): 4907.
https://doi.org/10.1182/blood-2023-188868
Published: 2023
Journal Articles

Prospective Evaluation of a Defined Replacement Protocol for Peri-Operative Hemostasis in Patients with Severe Hemophilia Α with and without Inhibitors on Emicizumab Prophylaxis Undergoing Elective Major Surgeries. (EmiSurg Study)

Aby Abraham, Fouzia N., Sandeep Albert, Tulasi Geevar, Rutvi Gautam Dave, Suchita Chase, Vinay Rao, Paul M Jacob, Ajoy Mathew, Abraham Sunder Sigh, Anbu Jeba, Kavitha M Lakshmi, Sushil Selvarajan, Sharon Anbumalar Lionel, Uday Kulkarni, Anup J Devasia, Anu Korula, Biju George, Vikram Mathews, Sukesh Nair, Alok Srivastava
Journal: Blood
Blood (2023) 142 (Supplement 1): 5513.
https://doi.org/10.1182/blood-2023-184564
Published: 2023